249 related articles for article (PubMed ID: 30169520)
1. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
2. Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases.
Holubyev K; Bratengeier K; Gainey M; Polat B; Flentje M
Radiat Oncol; 2013 Nov; 8():263. PubMed ID: 24207129
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.
Wang Y; Efstathiou JA; Sharp GC; Lu HM; Ciernik IF; Trofimov AV
Med Phys; 2011 Aug; 38(8):4623-33. PubMed ID: 21928635
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):444-453. PubMed ID: 26907917
[TBL] [Abstract][Full Text] [Related]
5. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
6. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
[TBL] [Abstract][Full Text] [Related]
7. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer.
Prabhakar R; Oates R; Jones D; Kron T; Cramb J; Foroudi F; Geso M; Gill S
Med Dosim; 2014; 39(1):38-43. PubMed ID: 24412028
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric evaluation of image-guided radiation therapy for prostate cancer.
Shan G; Hu W; Chen L; Price RA; Ma CC
Med Dosim; 2021 Summer; 46(2):117-126. PubMed ID: 33020024
[TBL] [Abstract][Full Text] [Related]
9. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
11. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
12. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
13. Using daily diagnostic quality images to validate planning margins for prostate interfractional variations.
Li W; Vassil A; Godley A; Mossolly LM; Shang Q; Xia P
J Appl Clin Med Phys; 2016 May; 17(3):61-74. PubMed ID: 27167262
[TBL] [Abstract][Full Text] [Related]
14. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
[TBL] [Abstract][Full Text] [Related]
15. Effects of organ motion on proton prostate treatments, as determined from analysis of daily CT imaging for patient positioning.
Maeda Y; Sato Y; Shibata S; Bou S; Yamamoto K; Tamamura H; Fuwa N; Takamatsu S; Sasaki M; Tameshige Y; Kume K; Minami H; Saga Y; Saito M
Med Phys; 2018 May; 45(5):1844-1856. PubMed ID: 29574901
[TBL] [Abstract][Full Text] [Related]
16. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
18. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins.
Gill SK; Reddy K; Campbell N; Chen C; Pearson D
J Appl Clin Med Phys; 2015 Nov; 16(6):252–262. PubMed ID: 26699581
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
20. Effect of accounting for interfractional CTV shape variations in PTV margins on prostate cancer radiation treatment plans.
Hirose TA; Arimura H; Shibayama Y; Fukunaga JI; Ohga S
Phys Med; 2018 Oct; 54():66-76. PubMed ID: 30337012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
